[
    [
        {
            "time": "2018-10-18",
            "original_text": "Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion",
            "features": {
                "keywords": [
                    "Novartis",
                    "Endocyte",
                    "Cancer-Drug",
                    "Acquisition",
                    "$2.1 Billion"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "2018-10-18",
            "original_text": "Close Update: Stocks Slump Thursday Amid Interest Rate, Economic Growth Concerns",
            "features": {
                "keywords": [
                    "Stocks",
                    "Slump",
                    "Interest Rate",
                    "Economic Growth"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-10-18",
            "original_text": "PTI Jumps Over 400% On CF Data, GRTS, YMAB March Ahead, NVS Acquires ECYT",
            "features": {
                "keywords": [
                    "PTI",
                    "CF Data",
                    "GRTS",
                    "YMAB",
                    "NVS",
                    "ECYT"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-10-18",
            "original_text": "Health Care Sector Update for 10/18/2018: ECYT,EIGR,NVS,PTI,ACRS",
            "features": {
                "keywords": [
                    "Health Care",
                    "Sector Update",
                    "ECYT",
                    "EIGR",
                    "NVS",
                    "PTI",
                    "ACRS"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-10-18",
            "original_text": "Novartis Missed Revenue Estimates in Q3 2018",
            "features": {
                "keywords": [
                    "Novartis",
                    "Missed",
                    "Revenue Estimates",
                    "Q3 2018"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-10-18",
            "original_text": "Mid-Day Update: U.S. Stocks Skid as Mnuchin Pulls Out of Saudi Conference, Italian Rout Triggered by Draghi",
            "features": {
                "keywords": [
                    "U.S. Stocks",
                    "Skid",
                    "Mnuchin",
                    "Saudi Conference",
                    "Italian Rout",
                    "Draghi"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 3,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-10-18",
            "original_text": "FDA snubs Novartis bid to repurpose inflammation drug for heart attacks",
            "features": {
                "keywords": [
                    "FDA",
                    "snubs",
                    "Novartis",
                    "inflammation drug",
                    "heart attacks"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]